337 related articles for article (PubMed ID: 17852796)
1. Autoantibodies to the proteasome in monosymptomatic optic neuritis may predict progression to multiple sclerosis.
Beyer NH; Milthers J; Bonde Lauridsen AM; Houen G; Lautrup Frederiksen J
Scand J Clin Lab Invest; 2007; 67(7):696-706. PubMed ID: 17852796
[TBL] [Abstract][Full Text] [Related]
2. Prognostic value of cerebrospinal fluid electrophoresis in optic neuritis and suspected multiple sclerosis.
Corridori F; Salmaggi A; Bortolami C; La Mantia L; Milanese C; Campi A; Cerrato D; Nespolo A
Ital J Neurol Sci; 1987 Jun; Suppl 6():77-80. PubMed ID: 3654181
[TBL] [Abstract][Full Text] [Related]
3. Oligoclonal bands in multiple sclerosis cerebrospinal fluid: an update on methodology and clinical usefulness.
Link H; Huang YM
J Neuroimmunol; 2006 Nov; 180(1-2):17-28. PubMed ID: 16945427
[TBL] [Abstract][Full Text] [Related]
4. Oligoclonal bands predict multiple sclerosis after optic neuritis: a literature survey.
Skov AG; Skov T; Frederiksen JL
Mult Scler; 2011 Apr; 17(4):404-10. PubMed ID: 21159718
[TBL] [Abstract][Full Text] [Related]
5. Detection of antibodies to the 20s proteasome by ELISA.
Jørgensen KM; Frederiksen JL; Nielsen CT; Houen G
J Immunoassay Immunochem; 2013; 34(4):384-92. PubMed ID: 23859789
[TBL] [Abstract][Full Text] [Related]
6. NMO-IgG predicts the outcome of recurrent optic neuritis.
Matiello M; Lennon VA; Jacob A; Pittock SJ; Lucchinetti CF; Wingerchuk DM; Weinshenker BG
Neurology; 2008 Jun; 70(23):2197-200. PubMed ID: 18434643
[TBL] [Abstract][Full Text] [Related]
7. A long-term prospective study of optic neuritis: evaluation of risk factors.
Sandberg-Wollheim M; Bynke H; Cronqvist S; Holtås S; Platz P; Ryder LP
Ann Neurol; 1990 Apr; 27(4):386-93. PubMed ID: 2353793
[TBL] [Abstract][Full Text] [Related]
8. Prognosis of optic neuritis with special reference to cerebrospinal fluid immunoglobulins and measles virus antibodies.
Nikoskelainen E; Frey H; Salmi A
Ann Neurol; 1981 Jun; 9(6):545-50. PubMed ID: 7259116
[TBL] [Abstract][Full Text] [Related]
9. Correlation of clinical, magnetic resonance imaging, and cerebrospinal fluid findings in optic neuritis.
Jacobs LD; Kaba SE; Miller CM; Priore RL; Brownscheidle CM
Ann Neurol; 1997 Mar; 41(3):392-8. PubMed ID: 9066361
[TBL] [Abstract][Full Text] [Related]
10. [Neurofilament protein light in multiple sclerosis].
Zhang Y; Li X; Qiao J
Zhonghua Yi Xue Za Zhi; 2007 Oct; 87(39):2745-9. PubMed ID: 18167263
[TBL] [Abstract][Full Text] [Related]
11. Specificity and correlation with disease activity of cerebrospinal fluid osteopontin levels in patients with multiple sclerosis.
Chowdhury SA; Lin J; Sadiq SA
Arch Neurol; 2008 Feb; 65(2):232-5. PubMed ID: 18268193
[TBL] [Abstract][Full Text] [Related]
12. [IGG index or oligoclonal bands in the diagnosis of disseminated sclerosis].
Sellebjerg F; Frederiksen JL
Ugeskr Laeger; 1993 Feb; 155(8):558-60. PubMed ID: 8451791
[TBL] [Abstract][Full Text] [Related]
13. An N-glucosylated peptide detecting disease-specific autoantibodies, biomarkers of multiple sclerosis.
Lolli F; Mulinacci B; Carotenuto A; Bonetti B; Sabatino G; Mazzanti B; D'Ursi AM; Novellino E; Pazzagli M; Lovato L; Alcaro MC; Peroni E; Pozo-Carrero MC; Nuti F; Battistini L; Borsellino G; Chelli M; Rovero P; Papini AM
Proc Natl Acad Sci U S A; 2005 Jul; 102(29):10273-8. PubMed ID: 16014416
[TBL] [Abstract][Full Text] [Related]
14. Tau protein: a possible prognostic factor in optic neuritis and multiple sclerosis.
Frederiksen J; Kristensen K; Bahl JM; Christiansen M
Mult Scler; 2012 May; 18(5):592-9. PubMed ID: 21969238
[TBL] [Abstract][Full Text] [Related]
15. Cerebrospinal fluid analysis in the diagnosis of multiple sclerosis.
Thompson EJ; Freedman MS
Adv Neurol; 2006; 98():147-60. PubMed ID: 16400832
[No Abstract] [Full Text] [Related]
16. Lipid-specific immunoglobulin M in CSF predicts adverse long-term outcome in multiple sclerosis.
Thangarajh M; Gomez-Rial J; Hedström AK; Hillert J; Alvarez-Cermeño JC; Masterman T; Villar LM
Mult Scler; 2008 Nov; 14(9):1208-13. PubMed ID: 18755821
[TBL] [Abstract][Full Text] [Related]
17. [Primary progressive forms of multiple sclerosis: application of the new diagnostic criteria in French].
De Seze J; Mackowiak A; Stojkovic T; Ferriby D; Hautecoeur P; Vermersch P
Rev Neurol (Paris); 2002 Mar; 158(3):341-5. PubMed ID: 11976594
[TBL] [Abstract][Full Text] [Related]
18. The predictive value of intrathecal immunoglobulin synthesis and magnetic resonance imaging in acute isolated syndromes for subsequent development of multiple sclerosis.
Sharief MK; Thompson EJ
Ann Neurol; 1991 Feb; 29(2):147-51. PubMed ID: 2012384
[TBL] [Abstract][Full Text] [Related]
19. The contribution of cerebrospinal fluid oligoclonal bands to the early diagnosis of multiple sclerosis.
Zipoli V; Hakiki B; Portaccio E; Lolli F; Siracusa G; Giannini M; Pantoni L; Pescini F; Sorbi S; Amato MP
Mult Scler; 2009 Apr; 15(4):472-8. PubMed ID: 19153171
[TBL] [Abstract][Full Text] [Related]
20. Proteasome antibodies in patients with cancer or multiple sclerosis.
Thuy-Tien H; Haugen M; Aarseth J; Storstein A; Vedeler CA
Scand J Immunol; 2008 Apr; 67(4):400-3. PubMed ID: 18266796
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
